Skip to main content
HairCited

미녹시딜 관련 원형 탈모증

A

총 21,842명의 참여자를 대상으로 한 48건의 연구(메타분석 2건, RCT 1건)에 근거합니다. 48건 중 37건의 연구에서 긍정적인 효과가 나타났습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata 효과: None None

대상 집단: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo 효과: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo 효과: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo 효과: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

연구

27416

참여자

Positive

A

등급

Referenced Papers

Dermatologic clinics 2025 5 인용
Pediatric dermatology 2025 5 인용
Journal of the … 2025 2 인용
International journal of … 2025 1 인용
Journal of clinical … 2025 1 인용
Archives of dermatological … 2025
International journal of … 2024 39 인용
American family physician 2024 8 인용
Skin health and … 2024 7 인용
Archives of dermatological … 2023 16 인용
The Cochrane database … 2023 2 인용
The Journal of … 2022 170 인용
Journal of the … 2022 90 인용
Skin appendage disorders 2022 7 인용
Journal of dermatological … 2021 51 인용
American journal of … 2020 127 인용
International journal of … 2020 58 인용
The journal of … 2020 3 인용
The Australasian journal … 2019 152 인용
American journal of … 2019 84 인용
Expert opinion on … 2019 34 인용
Klinicka onkologie : … 2019 11 인용
Journal of the … 2018 114 인용
Dermatology online journal 2018
American family physician 2017 141 인용
American journal of … 2017 32 인용
Actas dermo-sifiliograficas 2017 17 인용
Deutsches Arzteblatt international 2016 99 인용
Current problems in … 2015 322 인용
Canadian family physician … 2015 31 인용
The journal of … 2015 25 인용
Current problems in … 2015 18 인용
Der Internist 2015
American journal of … 2014 82 인용
Expert opinion on … 2014 57 인용
Giornale italiano di … 2014 18 인용
Giornale italiano di … 2014
International journal of … 2013 61 인용
Recent patents on … 2011 6 인용
Seminars in cutaneous … 2009 85 인용
American family physician 2009
The Cochrane database … 2008 222 인용
Current opinion in … 2008 31 인용
International journal of … 2007 185 인용
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 인용
Cleveland Clinic journal … 2005
Praxis 2003 28 인용
American family physician 2003 2 인용
American family physician 2003
American journal of … 2000 28 인용
International journal of … 1999 16 인용
Dermatologic clinics 1998 121 인용
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 인용
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

topical:
2-5% solution, twice daily

상한량: 5% topical solution

연구에서 사용된 용량

용량 기간 효과 N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

권장 복용 시간: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

보고된 부작용

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

알려진 상호작용

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

일일 최대 섭취 허용량: 5% topical solution

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 미녹시딜 help with 원형 탈모증?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that 미녹시딜 may support 원형 탈모증 management. Our evidence grade is A (Strong Evidence).
How much 미녹시딜 should I take for 원형 탈모증?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 미녹시딜?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 미녹시딜 and 원형 탈모증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.